Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model

European Heart Journal

Volumn 33, Issue 1, 2012, Pages 120-128

  Larsen, Katarína ^a   Cheng, Caroline ^a   Tempel, Dennie ^a   Parker, Sherry ^b   Yazdani, Saami ^c   Den Dekker, Wijnand K ^a   Houtgraaf, Jaco H ^a   De Jong, Renate ^a   Swager Ten Hoor, Stijn ^a   Ligtenberg, Erik ^b   Hanson, Stephen R ^d,e   Rowland, Steve ^b   Kolodgie, Frank ^c   Serruys, Patrick W ^a   Virmani, Renu ^c   Duckers, Henricus J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b OrbusNeich   (United States)

^c CVPATH INSTITUTE   (United States)

^d Oregon Health and Science University Department of Biomedical Engineering   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bio engineered stent; CD34+ capture stent; Endothelial markers; Endothelial progenitor cells; Endothelium; Gene expression; Genous stent; In stent thrombosis; Re endothelialization

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIOVENOUS SHUNT; ARTICLE; BARE METAL STENT; BIOENGINEERED STENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELL; EX VIVO STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILIAC ARTERY; MALE; MONOCYTE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; SCANNING ELECTRON MICROSCOPY; STENT; STENT THROMBOSIS; THROMBOCYTE; THROMBOGENICITY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; ANTIGENS, CD34; ARTERIOVENOUS SHUNT, SURGICAL; BIOENGINEERING; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT OCCLUSION, VASCULAR; HEART CATHETERIZATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PAPIO; PLATELET ADHESIVENESS; RABBITS; STEM CELLS; STENTS;

EID: 84855498912     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr196     Document Type: Article

References (17)

1. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-353. (Pubitemid 39100452)
2. Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967. (Pubitemid 27087709)
3. Gulati R, Simari RD. Cell therapy for acute myocardial infarction. Med Clin North Am 2007;91:769-785; xiii.
4. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003;23:1185-1189. (Pubitemid 36871271)
5. Kipshidze N, Dangas G, Tsapenko M. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004;44:733-739. (Pubitemid 39099565)
6. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004;8:498-508. (Pubitemid 44145482)
7. Co M, Tay E, Lee CH. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J 2008;155:128-132. (Pubitemid 350234778)
8. Klomp M, Beijk MA, de Winter RJ. Genous endothelial progenitor cell-capturing stent system: a novel stent technology. Expert Rev Med Devices 2009;6:365-375.
9. Beijk MA, Klomp M, Verouden NJ. Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J 31:1055-1064.
10. Duckers HJ, Soullie T, den Heijer P. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention 2007;3:350-358.
11. Duckers HJ, Silber S, de Winter R. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 2007;3:67-75.
12. Segers D, Helderman F, Cheng C. Gelatinolytic activity in atherosclerotic plaques is highly localized and is associated with both macrophages and smooth muscle cells in vivo. Circulation 2007;115:609-616. (Pubitemid 46226171)
13. Granada JF, Inami S, Aboodi MS. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2010.
14. Harrison P, Goodall AH. 'Message in the platelet' - more than just vestigial mRNA! Platelets 2008;19:395-404.
15. Donahue BS, Gailani D, Mast AE. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass. J Thromb Haemost 2006;4:1011-1016.
16. Osterud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995;73:873-875.
17. Silber S, Damman P, Klomp M. Clinical results after coronary stenting with the Genous Bio-engineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention;6:819-825.